Why PCOS Is a Longevity Condition
PCOS is routinely framed as a reproductive and cosmetic condition: irregular periods, acne, hair growth. That understates it. Insulin resistance is a key feature for many women with PCOS, and the 2023 international guideline highlights cardiovascular risk factors, sleep apnea and psychological effects alongside the reproductive ones.1
In a meta-analysis, women with PCOS had three times the risk of type 2 diabetes and higher risks of high blood pressure (risk ratio 1.75) and non-fatal cerebrovascular events (1.41), with slightly higher total cholesterol and lower HDL; no significant increase in coronary events was found.2 Diabetes risk varies with ethnicity and weight.3 Endometrial cancer risk is about 2.8 times higher, and higher still in studies limited to younger women.4
The longevity-relevant point is that PCOS can be an early warning: the insulin resistance behind it also drives metabolic disease later in life. Addressing it early helps manage symptoms and long-term metabolic risk.
Exercise: A Core PCOS Intervention
Exercise targets insulin resistance directly. The international guideline emphasizes a healthy lifestyle, including physical activity, for women with PCOS.1 Each session improves insulin sensitivity for a day or more, and regular exercise helps with weight, mood and cardiovascular health.
Resistance training is particularly useful. Muscle is your largest insulin-sensitive tissue, so building it improves glucose disposal. Train two to three times a week with progressive overload.
Aerobic exercise (150+ minutes a week). Walking, cycling or swimming at a conversational pace builds the base that supports everything else.
Balance intensity with recovery. Two to three strength sessions, two to three aerobic sessions and one to two easier days a week is a sustainable mix for most people.
Nutrition: Targeting Insulin Resistance
Nutrition in PCOS should target insulin resistance. For women with excess weight, modest weight loss improves PCOS features, and the guideline emphasizes a healthy lifestyle with awareness of weight stigma.1
Prioritize protein. Enough protein improves satiety, preserves lean mass and blunts after-meal insulin rises. Spread it across meals; animal and plant sources both work.
Manage carbohydrate quality. The glycemic load of your diet matters more than total carbohydrate restriction. Focus on intact whole grains, legumes, and non-starchy vegetables. Pair carbohydrates with protein, fat, or fiber to blunt glucose response. Avoid liquid sugars, refined grains, and ultra-processed carbohydrates.
Overall dietary pattern. A Mediterranean-style pattern (olive oil, fish, vegetables, legumes, nuts) supports cardiometabolic health. Evidence comparing specific diets in PCOS is limited, so choose a healthy pattern you can sustain.
Time-restricted eating (a 12 to 14 hour overnight fast) is reasonable to try, but evidence in PCOS is limited.
Testing: The PCOS Longevity Panel
Fasting insulin and HOMA-IR — Can show insulin resistance while glucose is still normal, though they are not standardized for diagnosis. Track trends with your clinician.
Full androgen panel — Total and free testosterone, DHEA-S, androstenedione, and SHBG. SHBG is particularly useful because it falls with insulin resistance and rises with improvement — making it both a diagnostic and monitoring marker.
Lipids and blood pressure — PCOS is linked with higher total cholesterol, lower HDL and more high blood pressure.2 A lipid panel (with ApoB if available) and regular blood pressure checks are reasonable from early adulthood.
hs-CRP — A marker of inflammation. Persistently high values warrant a look for other causes.
Liver health — Fatty liver disease is more common in PCOS, and normal liver enzymes do not rule it out. Ask about imaging if your metabolic markers are abnormal.
Vitamin D and magnesium — Worth checking if your diet or sun exposure is limited; supplements have not been established as PCOS treatments.
Supplements and Medications with PCOS Evidence
Inositol — Widely used, but a 2024 meta-analysis that informed the international guideline found the evidence limited and inconclusive: possible benefits for some metabolic measures and, with D-chiro-inositol, ovulation, but no effect on other outcomes. It causes fewer stomach side effects than metformin.5
Omega-3 fatty acids — Lower triglycerides in general; evidence for PCOS-specific benefits is limited.
Vitamin D — Correct a deficiency if you have one; trials have not established vitamin D as a PCOS treatment.
Magnesium — Reasonable if your intake is low; not a PCOS treatment.
Metformin — A long-standing option for insulin resistance in PCOS. Compared with inositol, it may improve waist-hip ratio and excess hair growth, with more stomach side effects.5 GLP-1 medicines are increasingly used for PCOS with obesity. Discuss options with your doctor.
Spironolactone — An anti-androgen that helps excess hair growth and acne. It does not treat the metabolic side of PCOS, requires potassium monitoring, and is generally used with reliable contraception.
References
- 1Teede HJ, et al. "Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome." Eur J Endocrinol. 2023;189(2):G43-G64. PubMed · DOI
- 2Wekker V, et al. "Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis." Hum Reprod Update. 2020;26(6):942-960. PubMed · DOI
- 3Kakoly NS, et al. "Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression." Hum Reprod Update. 2018;24(4):455-467. PubMed · DOI
- 4Barry JA, et al. "Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis." Hum Reprod Update. 2014;20(5):748-58. PubMed · DOI
- 5Fitz V, et al. "Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines." J Clin Endocrinol Metab. 2024;109(6):1630-1655. PubMed · DOI